Navigation Links
ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
Date:8/19/2007

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the supplemental biologics license application (sBLA) for ORENCIA(R) (abatacept) for the treatment of pediatric patients with juvenile idiopathic arthritis (JIA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate (MTX) or tumor necrosis factor (TNF) antagonists.

This sBLA is based on data from a double-blind, randomized trial that consisted of three periods: a four-month open-label lead-in treatment period in which all participants (6-17 years old) received ORENCIA and both clinical response and safety were assessed (Period A), a six-month randomized double- blind withdrawal phase in which responders received either ORENCIA or placebo and time to disease flare and safety were assessed (Period B), and an open- label phase in which all participants received ORENCIA in order to assess long-term efficacy and safety (Period C).

ORENCIA, which was discovered and developed by Bristol-Myers Squibb, is currently approved for use in adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more DMARDs such as MTX or TNF antagonists. ORENCIA is a selective modulator of a co- stimulatory signal required for full T-cell activation.

About Juvenile Idiopathic Arthritis

JIA -- also commonly known as juvenile rheumatoid arthritis (JRA) -- is a chronic, autoimmune disease, causing chronic pain, stiffness and swelling of the joints, which may ultimately lead to joint damage and deformities. The disease usually begins be
'/>"/>

SOURCE Bristol-Myers Squibb Company

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
2. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
3. Materia Licenses Metathesis Catalyst Platform to Eisai
4. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
5. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
6. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
7. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
8. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
9. New Quality Control Systems for Every Laboratory Application
10. Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor AP 12009 to be Presented
11. Antares Pharma Announces Positive Results from Application Site Study for Anturol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Many new dentists ... can do to ensure that their practice will be a ... the basic supplies they use the most can make all ... many dentists have recently discovered that purchasing discount dental ... According to successful dentists across ...
(Date:7/24/2014)... KIRKLAND, Wash. , July 24, 2014 ... exhibiting at the 2014 National Association of State Veterans ... Carolina . The goal of the NASVH is ... receives the benefits, services, long term health care and ... sacrifice. With the InSite® Remote Dispensing ...
(Date:7/24/2014)... , July 24, 2014 Decision Resources ... in the EU5 countries ( France , ... , Spain and the ... view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid ... robust uptake of Relvar as a first-line LABA/ICS FDC ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3
... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that Bruce Cozadd ... 35th Annual Health Care Conference on Monday, May 3, 2010 at ... Boston, MA. , , , ... of the presentation may be accessed from the Investors section of the Jazz ...
... April 26 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... announced Paul F. Truex , Anthera,s President and Chief Executive Officer ... Boston, MA on Monday, May 3, 2010 at ... , , ...
Cached Medicine Technology:Anthera Pharmaceuticals to Present at Deutsche Bank Securities' 35th Annual Health Care Conference 2
(Date:7/24/2014)... A new study led by the Translational Genomics ... bacteria, viruses and the immune system during HIV infection. ... potential to infect others based on their blood ... virus in their semen despite having low levels in ... of the virus can be found in different parts ...
(Date:7/24/2014)... July 24, 2014 In signing ... President Obama cited the Atlanta BeltLine Workforce Partnership ... from across the country ( http://www.whitehouse.gov/ready-to-work ). ... essential pillar of U.S. economic strategy and profiled ... “This recognition from President Obama highlights the power ...
(Date:7/24/2014)... BOSTON -- A new study has shown that it is ... by measuring the short-term effects of that same exposure. The ... , will make it possible to develop simpler and cheaper ... , Despite an overall decrease in incidence of ... be diagnosed with the disease in their lifetime, and around ...
(Date:7/24/2014)... the Human Papillomavirus Vaccination (HPV) even after becoming ... test results than those who were never vaccinated. ... Transmitted Diseases . , Researchers from Boston ... Medicine conducted a cross-sectional study of 235 women ... testing. HPV status and demographic and behavioral characteristics ...
(Date:7/24/2014)... York, New York (PRWEB) July 24, 2014 ... testosterone lawsuit ( http://www.drugbot.com/testosterone/lawsuit/ ) against the manufacturer ... of the risks associated with the low testosterone ... complaint, which was filed in the Ontario Superior ... alleges that use of low testosterone therapy is ...
Breaking Medicine News(10 mins):Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5Health News:Researchers discover new way to determine cancer risk of chemicals 2Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 3
... related to aggressive cancers can actually improve the efficacy ... Priority Report in Cancer Research , published by ... Hu antigen R (HuR), is a stress response protein ... certain experimental settings, pancreatic cancer cells that overexpressed HuR ...
... ... receives U.S. FDA Approval , ... (Vocus) June 4, 2009-- A new wrinkle-smoother will be arriving in doctors, ... in the European Union, Brazil, Argentina and more than 26 countries worldwide is a ...
... Free Webcast on Making a Smooth Transition to the EMR ... (NYSE: IRM ), the global leader in information ... tips during an upcoming Webcast for how healthcare providers can ... In this free, hour-long Webcast, attendees will learn the chief ...
... Better diagnosis, treatments behind decrease, researchers say , WEDNESDAY, June ... to fewer deaths from the rupture of a blood vessel ... Known as a subarachnoid hemorrhage, this kind of rupture leads ... thin tissue that covers the brain. It can occur spontaneously, ...
... Information Exchange for Medicaid Beneficiaries, Powered by MedPlus Centergy(TM) ... Access to Patient Information and Better Health Outcomes , ... The Department of Health Care Finance, DHCF, the District,s ... information technology subsidiary of Quest Diagnostics Incorporated (NYSE: ...
... following was released today by 1st Class Kids: , ... Tournament to raise money in support of continued obesity ... filled with TopGolf Skills Challenges, game play, live entertainment, ... the need to raise awareness about childhood obesity. Additionally, ...
Cached Medicine News:Health News:Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 2Health News:New Option for Erasing Wrinkles 2Health News:New Option for Erasing Wrinkles 3Health News:New Option for Erasing Wrinkles 4Health News:Best Practices for Hospitals Moving to Electronic Medical Records 2Health News:Fewer Deaths Occurring From Brain Bleeds 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 3Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 4
Collars can be attach to any Pulse aprons....
This apron was designed by Pulse Medical-RCI for optimal protection. Your comfort is also a primary concern so a wide support belt and shoulder pads are standard. When properly fitted, an overlapping...
... necessary, the Two-Piece should be your ... comfort through more efficient distribution of ... vest comes with shoulder pads and ... well as an attached belt to ...
Quick Release buckle apron is user friendly with large support straps crisscrossing the back allowing proper placement of the belt at your waist....
Medicine Products: